Oxford University will be at the forefront of a multimillion-pound research program, which hopes to help develop new therapies for acute and chronic conditions by examining the effects of medical cannabis.
Dr. Raphael Mechoulam laid the scientific foundation upon which all modern cannabis knowledge is built.
Researchers report highest-resolution model to date of brain receptor behind marijuana’s high – Cannabis News
DALLAS – Researchers at UT Southwestern Medical Center report the most detailed 3-D structure to date of the brain receptor that binds and responds to the chemical at the root of marijuana’s high.
The receptor in the brain involved in the "high" people feel after smoking marijuana is revealed in a new, detailed, 3D image today, according to a new study.
Cannabinoids are almost exclusively found in cannabis, and have been shown to have a significant effect on chronic skin conditions.
Insys Therapeutics Inc. announced Tuesday, July 5, that the United States Food and Drug Administration (FDA) has approved the company’s drug Syndros, an orally administered liquid formulation of the synthetic cannabinoid dronabinol, according to a release.
The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.